AAAAAA
Results: 76-100/231
Authors:
GUERCI B
MEYER L
BOULLIER A
DURIEZ P
FRUCHART JC
DROUIN P
Citation: B. Guerci et al., INTRAPERITONEAL INSULIN INFUSION DOES NOT INFLUENCE LDL SUSCEPTIBILITY TO OXIDATION IN WELL-CONTROLLED IDDM PATIENTS, Diabetes, 46, 1997, pp. 624-624
Authors:
QUILLIOT D
WALTERS E
DURIEZ P
FRUCHART JC
DROUIN P
ZIEGLER O
Citation: D. Quilliot et al., APOLIPOPROTEIN A-IV IN PANCREATIC DIABETES AND IN TYPE-I DIABETES-MELLITUS, Diabetes, 46, 1997, pp. 842-842
Authors:
HENNUYER NM
POULAIN P
MADSEN L
BERGE RK
HOUDEBINE LM
BRANELLEC D
FRUCHART JC
AUWERX J
FIEVET C
DUVERGER N
STAELS B
Citation: Nm. Hennuyer et al., THE BENEFICIAL-EFFECTS OF FIBRATES ON HIGH-DENSITY-LIPOPROTEIN METABOLISM OCCUR INDEPENDENT OF ANY PEROXISOME PROLIFERATIVE RESPONSE, Circulation, 96(8), 1997, pp. 3698-3698
Authors:
DALLONGEVILLE J
LEBEL P
PARRA HJ
LUC G
FRUCHART JC
Citation: J. Dallongeville et al., POSTPRANDIAL LIPEMIA IS ASSOCIATED WITH INCREASED LEVELS OF APOLIPOPROTEIN A-IV IN THE TRIACYLGLYCEROL-RICH FRACTION AND DECREASED LEVELS IN THE DENSER PLASMA FRACTIONS, British Journal of Nutrition, 77(2), 1997, pp. 213-223
Authors:
CASTRO G
NIHOUL LP
DENGREMONT C
DEGEITERE C
DELFLY B
TAILLEUX A
FIEVET C
DUVERGER N
DENEFLE P
FRUCHART JC
RUBIN EM
Citation: G. Castro et al., CHOLESTEROL EFFLUX, LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY, AND PRE-BETA PARTICLE FORMATION BY SERUM FROM HUMAN APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-I APOLIPOPROTEIN A-II TRANSGENIC MICE CONSISTENT WITH THE LATTER BEING LESS EFFECTIVE FOR REVERSE CHOLESTEROL TRANSPORT, Biochemistry, 36(8), 1997, pp. 2243-2249
Authors:
LEBUFFE G
BOULLIER A
TAILLEUX A
DELFLY B
DUPUIS B
FRUCHART JC
DUVERGER N
EMMANUEL F
DENEFLE P
VALLET B
DURIEZ P
Citation: G. Lebuffe et al., ENDOTHELIAL-DERIVED VASORELAXATION IS IMPAIRED IN HUMAN APO A-I TRANSGENIC RABBITS, Biochemical and biophysical research communications, 241(1), 1997, pp. 205-211
Authors:
NAZIHSANDERSON F
PINCHON G
NION S
FRUCHART JC
DELBART C
Citation: F. Nazihsanderson et al., HDL3-SIGNALING IN HEPG(2) CELLS INVOLVES GLYCOSYL-PHOSPATIDYLINOSITOL-ANCHORED PROTEINS, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1346(1), 1997, pp. 45-60
Authors:
ROMON M
LEFUR C
LEBEL P
EDME JL
FRUCHART JC
DALLONGEVILLE J
Citation: M. Romon et al., CIRCADIAN VARIATION OF POSTPRANDIAL LIPEMIA, The American journal of clinical nutrition, 65(4), 1997, pp. 934-940
Authors:
LECERF JM
MASSON A
FRUCHART JC
BARD JM
Citation: Jm. Lecerf et al., SERUM LP AL LIPOPROTEIN PARTICLES AND OTHER ANTIATHEROGENIC LIPID PARAMETERS IN NORMOLIPIDEMIC OBESE SUBJECTS, Diabetes & metabolism, 22(5), 1996, pp. 331-340
Authors:
DALLONGEVILLE J
LEROY A
FRUCHART JC
Citation: J. Dallongeville et al., IMMUNOLOGICAL APPROACH TO LIPOPARTICLE METABOLISM, Journal of clinical ligand assay, 19(3), 1996, pp. 163-167
Authors:
DUVERGER N
VIGLIETTA C
BERTHOU L
EMMANUEL F
TAILLEUX A
PARMENTIERNIHOUL L
LAINE B
FIEVET C
CASTRO G
FRUCHART JC
HOUBEBINE LM
DENEFLE P
Citation: N. Duverger et al., TRANSGENIC RABBITS EXPRESSING HUMAN APOLIPOPROTEIN-A-I IN THE LIVER, Arteriosclerosis, thrombosis, and vascular biology, 16(12), 1996, pp. 1424-1429
Authors:
MCPHERSON R
AGNANI G
LAU P
FRUCHART JC
EDGAR AD
MARCEL YL
Citation: R. Mcpherson et al., ROLE OF LP A-I AND LP A-I A-II IN CHOLESTERYL ESTER TRANSFER PROTEIN-MEDIATED NEUTRAL LIPID TRANSFER STUDIES IN NORMAL SUBJECTS AND IN HYPERTRIGLYCERIDEMIC PATIENTS BEFORE AND AFTER FENOFIBRATE THERAPY/, Arteriosclerosis, thrombosis, and vascular biology, 16(11), 1996, pp. 1340-1346
Authors:
ARNADOTTIR M
BERG AL
DALLONGEVILLE J
FRUCHART JC
NILSSONEHLE P
BODVARSSON M
Citation: M. Arnadottir et al., ACTH LOWERS SERUM LP(A) AND LDL CHOLESTEROL CONCENTRATIONS BUT DOES NOT INFLUENCE TRIGLYCERIDE-METABOLISM IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 341-341
Authors:
HUGUE V
LESTAVEL S
KANDOUSSI M
DRACON M
FRUCHART JC
CLAVEY V
CACHERA C
Citation: V. Hugue et al., IN-VITRO CATABOLISM OF LP(A) FROM HEMODIALYSIS-PATIENTS BY FIBROBLASTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1167-1167
Authors:
TAILLEUX A
FRUCHART JC
Citation: A. Tailleux et Jc. Fruchart, HDL HETEROGENEITY AND ATHEROSCLEROSIS, Critical reviews in clinical laboratory sciences, 33(3), 1996, pp. 163-201
Authors:
DALLONGEVILLE J
MARECAUX N
RICHARD F
BONTE D
ZYLBERBERG G
FANTINO M
FRUCHART JC
AMOUYEL P
Citation: J. Dallongeville et al., CIGARETTE-SMOKING IS ASSOCIATED WITH DIFFERENCES IN NUTRITIONAL HABITS AND RELATED TO LIPOPROTEIN ALTERATIONS INDEPENDENTLY OF FOOD AND ALCOHOL INTAKE, European journal of clinical nutrition, 50(10), 1996, pp. 647-654
Authors:
GHALIM N
ADLOUNI A
SAILE R
PARRA HJ
BENSLIMANE A
BARD JM
FRUCHART JC
Citation: N. Ghalim et al., APOLIPOPROTEIN AIV OF HUMAN INTERSTITIAL FLUID IS ASSOCIATED WITH APOLIPOPROTEIN AI-CONTAINING BUT NOT WITH AII-CONTAINING PARTICLES, International journal of clinical & laboratory research, 26(4), 1996, pp. 224-228
Authors:
HUGUE V
KANDOUSSI M
PARRA HJ
DRACON M
FRUCHART JC
TACQUET A
CACHERA C
Citation: V. Hugue et al., ALTERATION OF THE LIPID AND APOLIPOPROTEIN CONTENTS OF LIPOPROTEIN(A)IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 11(5), 1996, pp. 825-829
Authors:
AGUIEAGUIE G
THERET N
CASTRO G
WRISEZ F
FRUCHART JC
LAMBERT B
Citation: G. Aguieaguie et al., INHIBITORY EFFECT OF HIGH-DENSITY-LIPOPROTEIN HDL(3) ON CYCLIC-AMP ACCUMULATION IN RAT ADIPOCYTES - POSSIBLE INVOLVEMENT OF A PERTUSSIS-TOXIN-SENSITIVE G-PROTEIN, Medical science research, 24(8), 1996, pp. 541-543
Authors:
BOSSU JP
CHARTIER FL
FRUCHART JC
AUWERX J
STAELS B
LAINE B
Citation: Jp. Bossu et al., 2 REGULATORY ELEMENTS OF SIMILAR STRUCTURE AND PLACED IN TANDEM ACCOUNT FOR THE REPRESSIVE ACTIVITY OF THE FIRST INTRON OF THE HUMAN APOLIPOPROTEIN A-II GENE, Biochemical journal, 318, 1996, pp. 547-553
Authors:
MAGRET V
ELKHALIL L
NAZIHSANDERSON F
MARTIN F
BOURRE JM
FRUCHART JC
DELBART C
Citation: V. Magret et al., ENTRY OF POLYUNSATURATED FATTY-ACIDS INTO THE BRAIN - EVIDENCE THAT HIGH-DENSITY LIPOPROTEIN-INDUCED METHYLATION OF PHOSPHATIDYLETHANOLAMINE AND PHOSPHOLIPASE A(2) ARE INVOLVED, Biochemical journal, 316, 1996, pp. 805-811
Authors:
READE V
MEZDOUR H
READE R
KANDOUSSI M
DRACON M
FRUCHART JC
CACHERA C
Citation: V. Reade et al., NEUTRAL-LIPID TRANSFERS AND CHOLESTERYL ESTER TRANSFER PROTEIN IN HEMODIALYZED PATIENTS, American journal of nephrology, 16(5), 1996, pp. 394-401
Authors:
KANDOUSSI AM
HUGUE V
PARRA HJ
DRACON M
FRUCHART JC
TACQUET A
CACHERA C
Citation: Am. Kandoussi et al., APOLIPOPROTEIN AI AND APOLIPOPROTEIN-B CONTAINING PARTICLE ANALYSIS IN NORMOLIPIDEMIC HEMODIALYZED PATIENTS - EVIDENCE OF FREE APOLIPOPROTEIN-E, American journal of nephrology, 16(4), 1996, pp. 287-292
Authors:
SICARD D
NOIRY JP
ABADIE E
APFELBAUM M
ARIE E
BECRET F
DUCIMETIERE P
MOLLARD JM
POCHET P
ROUFFY J
THOMAS D
VINCENS M
BERLIN I
BERTHEZENE F
BLANCHET F
BONNECARRERE M
BRUCKERT E
CLERC M
DAB W
DANINOS JM
DELAHAYE F
DELEBARRE P
DROUIN P
DUMONT E
FERRIERES J
FRUCHART JC
GASPARD P
GERSON M
GILSKI J
GROS M
IMBERT JC
JACOTOT B
JOURDE M
LIBERATI A
LINCKDUBOST M
MENARD JM
MICHEL JM
OLOMBEL MC
POLONOVSKI J
SALTIEL H
VALCKE JC
DURAND DV
Citation: D. Sicard et al., HYPOLIPEMIC DRUGS, Therapie, 51(6), 1996, pp. 623-626
Authors:
DUVERGER N
TREMP G
CAILLAUD JM
EMMANUEL F
CASTRO G
FRUCHART JC
STEINMETZ A
DENEFLE P
Citation: N. Duverger et al., PROTECTION AGAINST ATHEROGENESIS IN MICE MEDIATED BY HUMAN APOLIPOPROTEIN A-IV, Science, 273(5277), 1996, pp. 966-968